首页 > 最新文献

Structural Heart最新文献

英文 中文
Aims & Scope 目标及范围
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/S2474-8706(26)00036-9
{"title":"Aims & Scope","authors":"","doi":"10.1016/S2474-8706(26)00036-9","DOIUrl":"10.1016/S2474-8706(26)00036-9","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100827"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantification of Alpha-Gal Expression in Commercial BioProsthetic Heart Valves and Its Potential Mitigation 商业生物瓣膜α - gal表达的量化及其潜在的缓解作用
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-10-13 DOI: 10.1016/j.shj.2025.100739
Andrea Colli MD , Peter Zilla MD , Antonio Maria Calafiore MD , Massimo Padalino MD , Filippo Naso MLT, BSc , Isaac George MD

Background and Aims

Bioprosthetic heart valves (BHVs) are inherently susceptible to structural degeneration, driven by a combination of mechanical stress, lipid infiltration, glutaraldehyde-induced crosslinking instability, and progressive calcification. Recent evidence has implicated the αGal antigen (galactose-α-1,3-galactose) as an additional contributor to BHV deterioration through activation of innate immune pathways. The present study aims to: 1) perform a quantitative assessment of the residual presence of xenoantigens, specifically αGal, in a range of commercial BHV models; 2) evaluate the efficacy of an experimental polyphenol-based treatment in neutralizing these antigenic determinants; and 3) investigate the long-term stability of glutaraldehyde fixation concerning the potential re-exposure of αGal epitopes.

Methods

Twelve distinct BHV models were subjected to in vitro analysis for αGal antigen quantification both before and following application of an experimental polyphenol treatment. Additionally, glutaraldehyde-fixed bovine pericardial tissues were incubated in a physiologically mimetic, blood-like environment for up to 9 years in real-time to simulate the long-term behavior of BHV materials and assess antigen unmasking associated with glutaraldehyde degradation.

Results

The average count of the αGal epitope in original pericardial valve models was 4.18 ± 0.72 × 1011/10 mg of tissue, whereas porcine valve-derived prostheses exhibited a higher mean value of 8.51 ± 2.17 × 1011/10 mg. Treatment with the polyphenol formulation resulted in a marked reduction (approximately 99%) in detectable αGal epitopes. Furthermore, glutaraldehyde fixed pericardial tissues subjected to prolonged incubation demonstrated up to 60% re-exposure of previously masked αGal antigens after 9 years, consistent with a progressive compromise of glutaraldehyde crosslinking integrity.

Conclusion

The data confirm that commercially available BHVs retain a substantial immunogenic burden attributable to αGal xenoantigens. Importantly, the overtime degradation of glutaraldehyde crosslinks facilitates the gradual re-exhibition of these epitopes, potentially undermining long-term valve performance. The pronounced efficacy of polyphenol-based treatment in inhibiting αGal antigens highlights its promise as a biocompatibility-enhancing pretreatment strategy for next-generation BHVs.
背景和目的生物人工心脏瓣膜(bhv)在机械应力、脂质浸润、戊二醛诱导的交联不稳定性和进行性钙化的共同作用下,天生就容易发生结构退化。最近的证据表明,αGal抗原(半乳糖-α-1,3-半乳糖)是通过激活先天免疫途径导致BHV恶化的另一个因素。本研究旨在:1)在一系列商业BHV模型中定量评估异种抗原,特别是αGal的残留存在;2)评估基于多酚的实验性治疗在中和这些抗原决定因子方面的功效;3)研究戊二醛固定对αGal表位再暴露的长期稳定性。方法采用体外α - gal抗原定量分析方法,对12种不同BHV模型进行多酚处理前后α - gal抗原定量分析。此外,将戊二醛固定的牛心包组织在生理模拟、类似血液的环境中实时培养长达9年,以模拟BHV材料的长期行为,并评估与戊二醛降解相关的抗原揭露。结果原始心包瓣膜模型αGal表位的平均计数为4.18±0.72 × 1011/10 mg,猪瓣膜模型αGal表位的平均值为8.51±2.17 × 1011/10 mg。用多酚制剂处理导致可检测的αGal表位显著减少(约99%)。此外,经长时间培养的戊二醛固定心包组织显示,在9年后,高达60%的先前被掩盖的αGal抗原再次暴露,这与戊二醛交联完整性的进行性损害一致。结论市售bhv具有αGal异种抗原的免疫原性负担。重要的是,戊二醛交联的长期降解促进了这些表位的逐渐重新展示,潜在地破坏了长期的阀门性能。基于多酚的治疗在抑制αGal抗原方面的显著效果突出了其作为下一代bhv生物相容性增强预处理策略的前景。
{"title":"Quantification of Alpha-Gal Expression in Commercial BioProsthetic Heart Valves and Its Potential Mitigation","authors":"Andrea Colli MD ,&nbsp;Peter Zilla MD ,&nbsp;Antonio Maria Calafiore MD ,&nbsp;Massimo Padalino MD ,&nbsp;Filippo Naso MLT, BSc ,&nbsp;Isaac George MD","doi":"10.1016/j.shj.2025.100739","DOIUrl":"10.1016/j.shj.2025.100739","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Bioprosthetic heart valves (BHVs) are inherently susceptible to structural degeneration, driven by a combination of mechanical stress, lipid infiltration, glutaraldehyde-induced crosslinking instability, and progressive calcification. Recent evidence has implicated the αGal antigen (galactose-α-1,3-galactose) as an additional contributor to BHV deterioration through activation of innate immune pathways. The present study aims to: 1) perform a quantitative assessment of the residual presence of xenoantigens, specifically αGal, in a range of commercial BHV models; 2) evaluate the efficacy of an experimental polyphenol-based treatment in neutralizing these antigenic determinants; and 3) investigate the long-term stability of glutaraldehyde fixation concerning the potential re-exposure of αGal epitopes.</div></div><div><h3>Methods</h3><div>Twelve distinct BHV models were subjected to in vitro analysis for αGal antigen quantification both before and following application of an experimental polyphenol treatment. Additionally, glutaraldehyde-fixed bovine pericardial tissues were incubated in a physiologically mimetic, blood-like environment for up to 9 years in real-time to simulate the long-term behavior of BHV materials and assess antigen unmasking associated with glutaraldehyde degradation.</div></div><div><h3>Results</h3><div>The average count of the αGal epitope in original pericardial valve models was 4.18 ± 0.72 × 10<sup>11</sup>/10 mg of tissue, whereas porcine valve-derived prostheses exhibited a higher mean value of 8.51 ± 2.17 × 10<sup>11</sup>/10 mg. Treatment with the polyphenol formulation resulted in a marked reduction (approximately 99%) in detectable αGal epitopes. Furthermore, glutaraldehyde fixed pericardial tissues subjected to prolonged incubation demonstrated up to 60% re-exposure of previously masked αGal antigens after 9 years, consistent with a progressive compromise of glutaraldehyde crosslinking integrity.</div></div><div><h3>Conclusion</h3><div>The data confirm that commercially available BHVs retain a substantial immunogenic burden attributable to αGal xenoantigens. Importantly, the overtime degradation of glutaraldehyde crosslinks facilitates the gradual re-exhibition of these epitopes, potentially undermining long-term valve performance. The pronounced efficacy of polyphenol-based treatment in inhibiting αGal antigens highlights its promise as a biocompatibility-enhancing pretreatment strategy for next-generation BHVs.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100739"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146090676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor Response 致编辑的信
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2026-01-20 DOI: 10.1016/j.shj.2025.100783
Revathy Sampath-Kumar MD, Ehtisham Mahmud MD
{"title":"Letter to the Editor Response","authors":"Revathy Sampath-Kumar MD,&nbsp;Ehtisham Mahmud MD","doi":"10.1016/j.shj.2025.100783","DOIUrl":"10.1016/j.shj.2025.100783","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100783"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146039307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of ICD-10-CM Z-Coded Social Determinants of Health on Transcatheter Aortic Valve Replacement–Related Outcomes ICD-10-CM z编码健康社会决定因素对经导管主动脉瓣置换术相关结果的影响
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-12-19 DOI: 10.1016/j.shj.2025.100789
Ramzi Ibrahim MD , Matthew Romero BS , Hoang Nhat Pham MD , Ahmed K. Mahmoud MD , Kristen A. Sell-Dottin MD , John P. Sweeney MD , F. David Fortuin MD , Eugene Yang MD, MS , Kwan Lee MD , Said Alsidawi MD , Sadeer Al-Kindi MD , Chadi Ayoub MBBS, PhD , Reza Arsanjani MD
{"title":"Impact of ICD-10-CM Z-Coded Social Determinants of Health on Transcatheter Aortic Valve Replacement–Related Outcomes","authors":"Ramzi Ibrahim MD ,&nbsp;Matthew Romero BS ,&nbsp;Hoang Nhat Pham MD ,&nbsp;Ahmed K. Mahmoud MD ,&nbsp;Kristen A. Sell-Dottin MD ,&nbsp;John P. Sweeney MD ,&nbsp;F. David Fortuin MD ,&nbsp;Eugene Yang MD, MS ,&nbsp;Kwan Lee MD ,&nbsp;Said Alsidawi MD ,&nbsp;Sadeer Al-Kindi MD ,&nbsp;Chadi Ayoub MBBS, PhD ,&nbsp;Reza Arsanjani MD","doi":"10.1016/j.shj.2025.100789","DOIUrl":"10.1016/j.shj.2025.100789","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100789"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sheltering From the Storm: Advancing Radiation Protection in Interventional Echocardiography 躲避风暴:推进介入超声心动图的辐射防护
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-12-15 DOI: 10.1016/j.shj.2025.100784
Nishath Quader MD , Renuka Jain MD
{"title":"Sheltering From the Storm: Advancing Radiation Protection in Interventional Echocardiography","authors":"Nishath Quader MD ,&nbsp;Renuka Jain MD","doi":"10.1016/j.shj.2025.100784","DOIUrl":"10.1016/j.shj.2025.100784","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100784"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of a Dedicated Radioprotection Cabin for the Interventional Echocardiographer During Structural Heart Procedures 心脏结构手术中介入超声心动仪专用辐射防护舱的性能
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-11-10 DOI: 10.1016/j.shj.2025.100756
François Magniez MD , Luis Ammour PhD , Pierre-Guillaume Piriou MD , Nicolas Piriou MD , David Stevant MD , Quentin Bernard MD , Laurianne Le Gloan MD , Philippe Jaafar MD , Vincent Letocart MD , Julien Plessis MD , Thibaut Manigold MD , Robin Le Ruz MD , Pierre Yves Turgeon MD , Patrice Guerin MD, PhD

Background

Structural heart procedures performed under fluoroscopy and transesophageal echocardiography guidance require the expertise of an interventional echocardiographer in the heart team. Due to the proximity with the radiation source, the physician might be exposed to high radiation doses. This study aims to assess the interventional echocardiographer radioprotection by means of a dedicated cabin and evaluate its ergonomic characteristics.

Methods

This is an observational nonrandomized study comparing cumulative radiation exposure between a control arm, consisting of a standard lead glass panel, and the experimental arm using the dedicated radioprotective Echosafe cabin. All structural heart procedures requiring transesophageal echocardiography between July 2021 and April 2022 were included. Cumulative radiation exposure of the interventional echocardiographer was collected by the body part and the satisfaction of the heart team with the cabin was assessed with a questionnaire.

Results

A total of 64 procedures were included (24 controls and 40 with the cabin). The irradiation (as estimated by dose area product per procedure) was similar between the two groups (p = 0.94). The use of the cabin resulted in a numerically lower cumulative radiation dose to each body part. The mean overall reduction in radiation dose was estimated to be between 56 and 78% with the cabin. The most frequent negative aspects reported by the cabin users included difficulty moving the transesophageal echocardiography probe and the physical burden associated with initial installation.

Conclusions

This preliminary study suggests that radioprotection of the interventional echocardiographer can be increased during structural procedures by using a dedicated cabin. Further studies with larger sample sizes and different design will be needed to confirm the reduction in irradiation of the echocardiographer.
背景:在透视和经食管超声心动图指导下进行心脏结构手术需要心脏科介入超声心动图医师的专业知识。由于靠近辐射源,医生可能受到高剂量的辐射。本研究旨在评估介入超声心动仪专用舱室的放射防护,并评估其人体工程学特性。方法:这是一项观察性非随机研究,比较了由标准铅玻璃面板组成的对照臂和使用专用辐射防护Echosafe舱的实验臂之间的累积辐射暴露。包括2021年7月至2022年4月期间需要经食管超声心动图检查的所有结构性心脏手术。通过身体部位收集介入超声心动图员的累积辐射暴露量,并通过问卷调查评估心脏科团队对舱室的满意度。结果共纳入64例手术,其中对照组24例,带舱手术40例。两组的辐照量(按每次手术的剂量面积积估计)相似(p = 0.94)。舱室的使用导致每个身体部位的累积辐射剂量数值较低。据估计,有了机舱,辐射剂量的平均总减少量在56%到78%之间。客舱使用者报告的最常见的负面影响包括难以移动经食管超声心动图探头和初始安装带来的身体负担。结论本初步研究表明,在结构手术中,使用专用的超声心动图室可以提高介入超声心动图员的放射防护。进一步的研究需要更大的样本量和不同的设计来证实超声心动图仪辐照的减少。
{"title":"Performance of a Dedicated Radioprotection Cabin for the Interventional Echocardiographer During Structural Heart Procedures","authors":"François Magniez MD ,&nbsp;Luis Ammour PhD ,&nbsp;Pierre-Guillaume Piriou MD ,&nbsp;Nicolas Piriou MD ,&nbsp;David Stevant MD ,&nbsp;Quentin Bernard MD ,&nbsp;Laurianne Le Gloan MD ,&nbsp;Philippe Jaafar MD ,&nbsp;Vincent Letocart MD ,&nbsp;Julien Plessis MD ,&nbsp;Thibaut Manigold MD ,&nbsp;Robin Le Ruz MD ,&nbsp;Pierre Yves Turgeon MD ,&nbsp;Patrice Guerin MD, PhD","doi":"10.1016/j.shj.2025.100756","DOIUrl":"10.1016/j.shj.2025.100756","url":null,"abstract":"<div><h3>Background</h3><div>Structural heart procedures performed under fluoroscopy and transesophageal echocardiography guidance require the expertise of an interventional echocardiographer in the heart team. Due to the proximity with the radiation source, the physician might be exposed to high radiation doses. This study aims to assess the interventional echocardiographer radioprotection by means of a dedicated cabin and evaluate its ergonomic characteristics.</div></div><div><h3>Methods</h3><div>This is an observational nonrandomized study comparing cumulative radiation exposure between a control arm, consisting of a standard lead glass panel, and the experimental arm using the dedicated radioprotective Echosafe cabin. All structural heart procedures requiring transesophageal echocardiography between July 2021 and April 2022 were included. Cumulative radiation exposure of the interventional echocardiographer was collected by the body part and the satisfaction of the heart team with the cabin was assessed with a questionnaire.</div></div><div><h3>Results</h3><div>A total of 64 procedures were included (24 controls and 40 with the cabin). The irradiation (as estimated by dose area product per procedure) was similar between the two groups (<em>p</em> = 0.94). The use of the cabin resulted in a numerically lower cumulative radiation dose to each body part. The mean overall reduction in radiation dose was estimated to be between 56 and 78% with the cabin. The most frequent negative aspects reported by the cabin users included difficulty moving the transesophageal echocardiography probe and the physical burden associated with initial installation.</div></div><div><h3>Conclusions</h3><div>This preliminary study suggests that radioprotection of the interventional echocardiographer can be increased during structural procedures by using a dedicated cabin. Further studies with larger sample sizes and different design will be needed to confirm the reduction in irradiation of the echocardiographer.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100756"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Changes in Renal Function on Outcomes Following Mitral Transcatheter Edge-To-Edge Repair 二尖瓣边缘到边缘修复术后肾功能改变对预后的影响。
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-10-29 DOI: 10.1016/j.shj.2025.100747
Parth N. Patel MD , Olivia L. Hulme MD , Marc Allard-Ratick MD , Jay Khambhati MD , Amanda Stebbins MPH , Andrzej S. Kosinski PhD , Sreekanth Vemulapalli MD , Sammy Elmariah MD, MPH

Background

Hemodynamic changes following mitral transcatheter edge-to-edge repair (mTEER) may impact estimated glomerular filtration rate (eGFR), but whether changes in eGFR following mTEER are associated with subsequent clinical outcomes is not known. The objective of the study was to investigate procedure-related changes in eGFR and clinical outcomes following mTEER.

Methods

We studied patients in the Transcatheter Valve Therapy registry undergoing mTEER between 2013 and 2022 with available baseline and discharge eGFR. Multivariable linear regression identified baseline characteristics associated with changes in eGFR following mTEER. Cox proportional hazards models examined the adjusted association between improved (≥10% increase in eGFR), unchanged, and worsened renal function (≥10% decrease in eGFR) and survival at 1 year.

Results

Among 48,472 patients undergoing mTEER, 15.7% experienced improved renal function and 13.7% had worsened renal function. Cardiogenic shock within 24 hours, age >80, Black race, diabetes, heart failure within 2 weeks, and female sex were strongly associated with worsened renal function after mTEER. Compared to the group with no change in renal function, improved renal function was associated with a decreased risk of 1-year mortality (adjusted hazard ratio: 0.77; 95% CI 0.69-0.86, p < 0.001), whereas worsened renal function was associated with an increased risk of death at 1 year (adjusted hazard ratio: 2.85; 95% CI 2.64-3.08, p < 0.001).

Conclusions

Approximately 30% of patients experience marked changes in renal function following mTEER.
A greater than 10% increase or decrease in eGFR is independently associated with differences in 1-year survival. Careful attention to patients at greatest risk for worsened renal function after mTEER is warranted.
背景:二尖瓣经导管边缘到边缘修复(mTEER)后的血流动力学变化可能影响估计的肾小球滤过率(eGFR),但mTEER后eGFR的变化是否与随后的临床结果相关尚不清楚。该研究的目的是调查mTEER术后eGFR的手术相关变化和临床结果。方法:我们研究了2013年至2022年间接受mTEER的经导管瓣膜治疗登记的患者,这些患者具有可用的基线和出院eGFR。多变量线性回归确定了与mTEER后eGFR变化相关的基线特征。Cox比例风险模型检验了1年生存率与肾功能改善(eGFR升高≥10%)、肾功能不变和肾功能恶化(eGFR降低≥10%)之间的相关性。结果:48472例接受mTEER治疗的患者中,15.7%的患者肾功能改善,13.7%的患者肾功能恶化。24小时内心源性休克、年龄80 ~ 80岁、黑人、糖尿病、2周内心力衰竭、女性与mTEER术后肾功能恶化密切相关。与肾功能无变化组相比,肾功能改善与1年死亡风险降低相关(校正风险比:0.77;95% CI: 0.69-0.86, p < 0.001),而肾功能恶化与1年死亡风险增加相关(校正风险比:2.85;95% CI: 2.64-3.08, p < 0.001)。结论:大约30%的患者在mTEER后出现明显的肾功能改变。大于10%的eGFR升高或降低与1年生存率的差异独立相关。对mTEER术后肾功能恶化风险最大的患者给予密切关注是必要的。
{"title":"Impact of Changes in Renal Function on Outcomes Following Mitral Transcatheter Edge-To-Edge Repair","authors":"Parth N. Patel MD ,&nbsp;Olivia L. Hulme MD ,&nbsp;Marc Allard-Ratick MD ,&nbsp;Jay Khambhati MD ,&nbsp;Amanda Stebbins MPH ,&nbsp;Andrzej S. Kosinski PhD ,&nbsp;Sreekanth Vemulapalli MD ,&nbsp;Sammy Elmariah MD, MPH","doi":"10.1016/j.shj.2025.100747","DOIUrl":"10.1016/j.shj.2025.100747","url":null,"abstract":"<div><h3>Background</h3><div>Hemodynamic changes following mitral transcatheter edge-to-edge repair (mTEER) may impact estimated glomerular filtration rate (eGFR), but whether changes in eGFR following mTEER are associated with subsequent clinical outcomes is not known. The objective of the study was to investigate procedure-related changes in eGFR and clinical outcomes following mTEER.</div></div><div><h3>Methods</h3><div>We studied patients in the Transcatheter Valve Therapy registry undergoing mTEER between 2013 and 2022 with available baseline and discharge eGFR. Multivariable linear regression identified baseline characteristics associated with changes in eGFR following mTEER. Cox proportional hazards models examined the adjusted association between improved (≥10% increase in eGFR), unchanged, and worsened renal function (≥10% decrease in eGFR) and survival at 1 year.</div></div><div><h3>Results</h3><div>Among 48,472 patients undergoing mTEER, 15.7% experienced improved renal function and 13.7% had worsened renal function. Cardiogenic shock within 24 hours, age &gt;80, Black race, diabetes, heart failure within 2 weeks, and female sex were strongly associated with worsened renal function after mTEER. Compared to the group with no change in renal function, improved renal function was associated with a decreased risk of 1-year mortality (adjusted hazard ratio: 0.77; 95% CI 0.69-0.86, <em>p</em> &lt; 0.001), whereas worsened renal function was associated with an increased risk of death at 1 year (adjusted hazard ratio: 2.85; 95% CI 2.64-3.08, <em>p</em> &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>Approximately 30% of patients experience marked changes in renal function following mTEER.</div><div>A greater than 10% increase or decrease in eGFR is independently associated with differences in 1-year survival. Careful attention to patients at greatest risk for worsened renal function after mTEER is warranted.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 3","pages":"Article 100747"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic Valve Trans-Leaflet Lithotripsy for Targeted Periannular Calcium Modification Prior to TAVI 主动脉瓣经小叶碎石术在TAVI术前靶向环周钙修饰
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 Epub Date: 2025-11-29 DOI: 10.1016/j.shj.2025.100771
Cheuk Bong Ho MBBS, Hon Yeung Ko MBChB, Michael Chi Shing Chiang MBBS, Shing Fung Chui MBChB, Ka Chun Chan MBBS, Kam Tim Chan MBBS, Eric Chi Yuen Wong MBBS, Michael Kang Yin Lee MBBS
{"title":"Aortic Valve Trans-Leaflet Lithotripsy for Targeted Periannular Calcium Modification Prior to TAVI","authors":"Cheuk Bong Ho MBBS,&nbsp;Hon Yeung Ko MBChB,&nbsp;Michael Chi Shing Chiang MBBS,&nbsp;Shing Fung Chui MBChB,&nbsp;Ka Chun Chan MBBS,&nbsp;Kam Tim Chan MBBS,&nbsp;Eric Chi Yuen Wong MBBS,&nbsp;Michael Kang Yin Lee MBBS","doi":"10.1016/j.shj.2025.100771","DOIUrl":"10.1016/j.shj.2025.100771","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 2","pages":"Article 100771"},"PeriodicalIF":2.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation Realities: Radiation Safety Practices and Awareness Among Interventional Echocardiographers in the United States 辐射现实:介入超声心动图医师在美国的辐射安全实践和意识
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 Epub Date: 2025-12-15 DOI: 10.1016/j.shj.2025.100785
Priscilla Wessly MD , Enrique Garcia-Sayan MD , Nishath Quader MD , Stephen Little MD , Omar Khalique MD , Renuka Jain MD

Background

With the rise of structural heart interventions (SHIs), interventional echocardiographers (IEs) face significant radiation exposure in catheterization laboratories. However, US-specific radiation safety practices remain understudied. This study aims to address radiation safety practices and concerns among US IEs, focusing on occupational risks and sex-specific challenges.

Methods

A 21-item online survey was conducted from March to June 2025, targeting US IEs through a multifaceted recruitment strategy. It assessed demographics, SHI frequency, radiation monitoring, shielding practices, and reproductive health concerns. Descriptive statistics summarized responses, with sex-specific analyses for female IEs.

Results

Of 69 respondents (64% [n = 44] men, 36% [n = 25] women), 88% (n = 61) worked in tertiary care settings and 46% (n = 32) guided SHIs several times weekly. Key gaps were identified, including 18% (n = 17) not using dosimeters, 64% (n = 44) never receiving exposure notifications, and 80% (n = 55) lacking awareness of their personal annual radiation dose. In addition, 30% (n = 21) had no radiation safety training, and 75% (n = 52) reported insufficient radiation protection in their catheterization laboratory. Reproductive health concerns affected 71% (n = 49) of IEs. Among female IEs, 56% (n = 14) reported an influence on pregnancy planning, 32% (n = 8) noted career concerns owing to maternity, and 63% of those who had had a pregnancy (n = 12/19) performed SHIs during pregnancy, with 7% taking no additional precautions.

Conclusions

US IEs face critical radiation safety gaps, including inadequate monitoring, training, and shielding, with pronounced reproductive and career concerns among female IEs. Tailored protocols, enhanced shielding, and pregnancy-specific precautions are urgently needed to ensure the safety and well-being of IEs.
随着结构性心脏介入(SHIs)的兴起,介入超声心动图医师(IEs)在导管实验室面临着显著的辐射暴露。然而,美国特有的辐射安全措施仍未得到充分研究。本研究旨在解决美国工业工程师的辐射安全实践和担忧,重点关注职业风险和性别特异性挑战。方法于2025年3月至6月进行了一项21项的在线调查,通过多方面的招聘策略针对美国的工程师。它评估了人口统计、辐射辐射频率、辐射监测、屏蔽做法和生殖健康问题。描述性统计总结了调查结果,并对女性IEs进行了性别分析。结果69名受访者中(64% [n = 44]男性,36% [n = 25]女性),88% (n = 61)在三级保健机构工作,46% (n = 32)每周指导SHIs几次。已确定的主要差距包括18% (n = 17)未使用剂量计,64% (n = 44)从未收到照射通知,80% (n = 55)缺乏对个人年辐射剂量的认识。此外,30% (n = 21)的患者没有接受过辐射安全培训,75% (n = 52)的患者报告其导管室的辐射防护不足。生殖健康问题影响了71%的产妇(n = 49)。在女性IEs中,56% (n = 14)报告了对怀孕计划的影响,32% (n = 8)指出了因生育而引起的职业担忧,63%怀孕过的人(n = 12/19)在怀孕期间进行了SHIs, 7%没有采取额外的预防措施。结论美国放射学专业人员面临严重的辐射安全缺口,包括监测、培训和防护不足,女性放射学专业人员存在明显的生殖和职业担忧。为确保新生儿的安全和健康,迫切需要量身定制的方案、增强的防护和针对妊娠的预防措施。
{"title":"Radiation Realities: Radiation Safety Practices and Awareness Among Interventional Echocardiographers in the United States","authors":"Priscilla Wessly MD ,&nbsp;Enrique Garcia-Sayan MD ,&nbsp;Nishath Quader MD ,&nbsp;Stephen Little MD ,&nbsp;Omar Khalique MD ,&nbsp;Renuka Jain MD","doi":"10.1016/j.shj.2025.100785","DOIUrl":"10.1016/j.shj.2025.100785","url":null,"abstract":"<div><h3>Background</h3><div>With the rise of structural heart interventions (SHIs), interventional echocardiographers (IEs) face significant radiation exposure in catheterization laboratories. However, US-specific radiation safety practices remain understudied. This study aims to address radiation safety practices and concerns among US IEs, focusing on occupational risks and sex-specific challenges.</div></div><div><h3>Methods</h3><div>A 21-item online survey was conducted from March to June 2025, targeting US IEs through a multifaceted recruitment strategy. It assessed demographics, SHI frequency, radiation monitoring, shielding practices, and reproductive health concerns. Descriptive statistics summarized responses, with sex-specific analyses for female IEs.</div></div><div><h3>Results</h3><div>Of 69 respondents (64% [n = 44] men, 36% [n = 25] women), 88% (n = 61) worked in tertiary care settings and 46% (n = 32) guided SHIs several times weekly. Key gaps were identified, including 18% (n = 17) not using dosimeters, 64% (n = 44) never receiving exposure notifications, and 80% (n = 55) lacking awareness of their personal annual radiation dose. In addition, 30% (n = 21) had no radiation safety training, and 75% (n = 52) reported insufficient radiation protection in their catheterization laboratory. Reproductive health concerns affected 71% (n = 49) of IEs. Among female IEs, 56% (n = 14) reported an influence on pregnancy planning, 32% (n = 8) noted career concerns owing to maternity, and 63% of those who had had a pregnancy (n = 12/19) performed SHIs during pregnancy, with 7% taking no additional precautions.</div></div><div><h3>Conclusions</h3><div>US IEs face critical radiation safety gaps, including inadequate monitoring, training, and shielding, with pronounced reproductive and career concerns among female IEs. Tailored protocols, enhanced shielding, and pregnancy-specific precautions are urgently needed to ensure the safety and well-being of IEs.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 2","pages":"Article 100785"},"PeriodicalIF":2.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pushing the Limits of Transcatheter Edge-to-Edge Repair: How Small Can the Mitral Valve Area Go? 突破经导管边缘到边缘修复的极限:二尖瓣面积能缩小到多小?
IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 Epub Date: 2025-12-09 DOI: 10.1016/j.shj.2025.100782
Gaspard Suc MD, PhD
{"title":"Pushing the Limits of Transcatheter Edge-to-Edge Repair: How Small Can the Mitral Valve Area Go?","authors":"Gaspard Suc MD, PhD","doi":"10.1016/j.shj.2025.100782","DOIUrl":"10.1016/j.shj.2025.100782","url":null,"abstract":"","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 2","pages":"Article 100782"},"PeriodicalIF":2.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Structural Heart
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1